Upgrade to SI Premium - Free Trial

Valeant Pharma (VRX) to Acquire Synergetics USA (SURG) for $6.50/Share + Milestones

September 2, 2015 8:02 AM
Synergetics USA, Inc. (NASDAQ: SURG) and Valeant Pharmaceuticals International ("Valeant"), a wholly-owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Hot Corp. News Management Comments Mergers and Acquisitions

Next Articles